Tomsicek Michael John insider trades
Tomsicek Michael John has filed 13 Form 4s with the SEC that we hold, for Milestone Pharmaceuticals Inc. (MIST) (Director), Acrivon Therapeutics, Inc. (ACRV) (Director) and CRISPR Therapeutics AG (CRSP) (Chief Financial Officer). Across all of them we count 1 purchase worth $79.8K and 2 sales worth $3.5M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 19,011 shares of CRISPR Therapeutics AG worth $2.6M, dated 2021-08-06. The first filing on our record is dated 2021-07-29 and the latest 2026-06-22.
Milestone Pharmaceuticals Inc. (MIST)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-10-19 | P, purchase reported on Form 4 | 15,000 | $79.8K | 2022-10-21 |
Acrivon Therapeutics, Inc. (ACRV)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
CRISPR Therapeutics AG (CRSP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-06 | S, sale reported on Form 4 | 19,011 | $2.6M | 2021-08-10 |
| 2021-08-06 | S, sale reported on Form 4 | 5,989 | $835.2K | 2021-08-10 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1570392) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms